Member Info for K3VMC

Smartass �no bounce for a very very long time folks imo i see 10p coming� You need to be pumping out the posts here, mate!! :-))

You obviously missed the UK Investor Show.

It can provide full remission and has NO harmful side-effects. BENLYSTA can cause serious side effects. Some of these side effects may cause death. It is not known if BENLYSTA causes these serious side effects. I lack a MA in Phylosophy, so i leave the interpretation of the previous statement to the dear reader.

Gives me no pleasure to post that, btw.

I remember my 5 year old son waking up with a bad earache. Half asleep, I gave him a spoonful of calomine lotion, instead of calpol. He started complaining about the taste. Nonsense, said I, and took a swig to show him there was nothing to moan about. OOPS!!

Nuff said.

Good for traders to get out with a profit. I am not in a rush to take profits. LUPUZOR is a drug that WORKS. Drugs that work make money. Often LOTS of money. If IMM need bigger studies to get statistical significance, it only takes time and money. If they don't have enough money, then they either sell LUPUZOR to big pharma, or join with big pharma. No-one is going to throw away a drug that offers 100% remission, with very low/no side-effects. Lots more to come here.

Who knows who is selling? Does it matter? Like yesterday, the bigger value trades are mostly buys. Happy with that.

nolupus, 7 people IS wrong. The clue is in the RNS.

7.6% full remission v 0% full remission? Buy a drug that CAN give complete remission, or one that CANNOT. What would any clinician, or patient, choose????

7.6% full remission v 0% full remission? Buy a drug that CAN give complete remission, or one that CANNOT. What would any clinician, or patient, choose????

Yost still has 1.8m short to close. Plenty of time for heaters to work, gas to flow, revenue to accrue. Happy to chill.

In 2016, Mr Masterman said he would take an offer of �10m. It was just a throwaway remark and the price of gold, and especially copper, have gone up markedly since then.

Looking good here.

Checked out his tweets. Hmmm. Interesting.

MatthewC, thank you!

$35m ebitda is achievable in 2019. Tonnage up 50%, price up 25%, Regua producing in Q4.

Following the successful BlackRock financing, which takes a senior secured position over both the Spanish and Portuguese assets, the Company's plan is to add very significant value to the copper gold assets during 2018 and add additional licenses and projects to the current portfolio prior to a potential spin-off or sale of Copper Gold Resources Plc. With management's priority and focus on the successful execution of La Parrilla, it is most efficient for the dedicated Portuguese technical team to advance the assets prior to spin-off or sale. I like the idea of adding new assets.

Who is DM, please?

ok, talking to myself now, I guess. Looks like the latest yost position change was on April 10th, down to 0.78%, Just another 1,851,252 to buy back then, give or take 10k. Best buythem now, while they are cheap.